tiprankstipranks
Anika Therapeutics (ANIK)
NASDAQ:ANIK

Anika Therapeutics (ANIK) Financial Statements

147 Followers

Anika Therapeutics Financial Overview

Anika Therapeutics's market cap is currently ―. The company's EPS TTM is $-5.643; its P/E ratio is -4.49; Anika Therapeutics is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 41.47M$ 44.30M$ 37.92M$ 39.62M$ 40.26M
Gross Profit$ 24.94M$ 28.97M$ 22.84M$ 24.13M$ 22.78M
EBIT$ -7.04M$ -3.07M$ -12.01M$ -6.67M$ -5.80M
EBITDA$ -2.95M$ 1.02M$ -7.92M$ -2.47M$ -2.30M
Net Income Common Stockholders$ -6.58M$ -2.74M$ 87.28M$ -4.91M$ -4.17M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 105.33M$ 101.81M$ 110.37M$ 120.95M$ 87.78M
Total Assets$ 328.16M$ 328.88M$ 339.07M$ 349.13M$ 347.75M
Total Debt$ 27.25M$ 27.77M$ 28.28M$ 28.82M$ 31.11M
Net Debt$ -78.08M$ -74.03M$ -82.09M$ -92.14M$ -56.67M
Total Liabilities$ 57.67M$ 54.87M$ 61.49M$ 63.56M$ 62.81M
Stockholders Equity$ 270.49M$ 274.01M$ 277.59M$ 285.56M$ 284.94M
Cash Flow-
Free Cash Flow$ 5.74M$ -9.75M$ -5.01M$ -2.05M$ 1.02M
Operating Cash Flow$ 6.49M$ -8.29M$ -3.62M$ 481.00K$ 2.71M
Investing Cash Flow$ -741.00K$ -1.46M$ -1.39M$ -2.53M$ -1.69M
Financing Cash Flow$ -110.00K$ -4.94M$ -1.61M$ 667.00K$ -4.61M
Currency in USD

Anika Therapeutics Earnings and Revenue History

Anika Therapeutics Debt to Assets

Anika Therapeutics Cash Flow

Anika Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis